[HTML][HTML] COVID-19 impact on the liver

L Baroiu, C Dumitru, A Iancu, AC Leșe… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) pandemic imposed arestructuring of
global health systems by rethinking spaces used for the care of these patients and the …

[HTML][HTML] The association of metabolic-associated fatty liver disease with clinical outcomes of COVID-19: a systematic review and meta-analysis

U Hayat, MZ Ashfaq, L Johnson, R Ford… - Kansas Journal of …, 2022 - ncbi.nlm.nih.gov
Methods A comprehensive search was conducted in the Cumulative Index of Nursing and
Allied Health (CINAHL), PubMed/Medline, and Embase for studies reporting MAFLD …

COVID‐19 mortality in cirrhosis is determined by cirrhosis‐associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry

JF Brozat, F Hanses, M Haelberger… - United European …, 2022 - Wiley Online Library
Abstract Background and Objective International registries have reported high mortality rates
in patients with liver disease and COVID‐19. However, the extent to which comorbidities …

Pathophysiology and molecular mechanisms of liver injury in severe forms of COVID-19: An integrative review

JL de Sousa Moreira, SMB Barbosa… - Clinics and Research in …, 2021 - Elsevier
Background and aims SARS-CoV-2 has primary pulmonary impairment, but other organs
such as the liver can also be affected. This implies a worsening of patient's prognosis and an …

[HTML][HTML] Vaccination in liver diseases and liver transplantation: recommendations, implications and opportunities in the post-Covid era

MP Ballester, R Jalan, G Mehta - JHEP Reports, 2023 - Elsevier
The interest in vaccination efficacy and toxicity has surged following the COVID-19
pandemic. Immune responses to several vaccines have been shown to be suboptimal in …

[HTML][HTML] Impact of COVID-19 on liver

YJ Su, CW Chang, MJ Chen, YC Lai - World journal of clinical …, 2021 - ncbi.nlm.nih.gov
The incidence of liver injury after coronavirus disease 2019 (COVID-19) infection ranged
from 15%-53%. The mechanism includes direct viral cytopathic effect, cytokinesis, and …

[HTML][HTML] Correlation between COVID-19 and hepatitis B: A systematic review

YF He, ZG Jiang, N Wu, N Bian… - World journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND There is growing evidence that patients with coronavirus disease 2019
(COVID-19) frequently present with liver impairment. Hepatitis B virus (HBV) remains a …

Abnormal liver function tests were associated with adverse clinical outcomes: an observational cohort study of 2,912 patients with covid-19

Y Lv, X Zhao, Y Wang, J Zhu, C Ma, X Feng… - Frontiers in …, 2021 - frontiersin.org
Background and Aim: The impact of liver function test (LFTs) abnormality on adverse clinical
outcomes in coronavirus disease 2019 (COVID-19) patients remains controversial. The aim …

[HTML][HTML] Non-alcoholic fatty liver disease (NAFLD) and COVID-19 outcomes: A systematic review, meta-analysis, and meta-regression

A Kurniawan, TI Hariyanto - Narra J, 2023 - ncbi.nlm.nih.gov
It is important to identify risk factors for poor outcomes of coronavirus disease 2019 (COVID-
19) patients. Currently, the correlation between non-alcoholic fatty liver disease (NAFLD) …

Unraveling the molecular and cellular pathogenesis of COVID-19-associated liver injury

H Akkiz - Viruses, 2023 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus (SARS-CoV-2) continues to cause substantial morbidity and mortality …